425: Strive CEO Posts on X Regarding Semler Merger

Strive's CEO Matthew Cole posted on X.com about the proposed business combination with Semler Scientific, Inc., emphasizing cautionary statements.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was posted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on October 28, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the transaction, outlining inherent risks and uncertainties.
• Investors are directed to additional SEC filings, including a forthcoming Registration Statement on Form S-4, for comprehensive information about the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a legal disclosure primarily outlining risks and procedural information related to a proposed business combination, maintaining a neutral but cautionary tone. While the merger itself is a significant event, the document's focus is on potential challenges and compliance.

Positives

• The proposed transaction aims for strategic benefits and financial benefits for the combined company.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, and problems arising from the implementation of Bitcoin treasury strategies.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction include anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. These forward-looking statements are based on assumptions and are subject to inherent risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted the communication on X.com on October 28, 2025, in connection with the proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity or at least one of the companies is involved in or considering significant exposure to digital assets, aligning with a growing trend among some corporations to integrate digital assets into their financial strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a potential risk.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Semler Scientific will be asked to approve the proposed transaction.
• Potential for dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a Proxy Statement of Semler Scientific, and a Prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Risk Management